especially Editor’s Portfolio holding Bristol-Myers Squibb (BMY), suggests Chuck Carlson, dividend reinvestment specialist and editor of DRIP Investor. The stock is down 25% since mid-February and is trading around its lowest level in a year. …
Stephanie Noviello, who joins from Bristol-Myers Squibb, will report into chief …
Bristol-Myers Squibb Company (NYSE:BMY), a Healthcare sector firm, traded 6.26 Million shares in last trading …
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), Bristol-Myers (BMY), and Time Warner (TWX). These …
Wall Street didn't like what Bristol-Myers Squibb (NYSE: BMY) had to say on Thursday -- at least not all of it -- when the big drugmaker reported its results for the first quarter of 2017. Bristol-Myers Squibb (BMS) handily beat the consensus …
SmarTrend identified a Downtrend for Bristol-Myer Sqb (NYSE:BMY) on March 23rd, 2018 at $63.00. In approximately 1 month, Bristol-Myer Sqb has returned 17.83% as of today's recent price of $51.76. In the past 52 weeks, shares of …
The Company is currently generating exceptional levels of free cash flow. If their 2020 project achieves anything like the £5 profit by 2221/22, the BMY SP will hopefully smash through a near 5 year consolidation. My Strong Buy is on a longer …
PHILADELPHIA, March 29, 2018 /PRNewswire/ -- Kehoe Law Firm, P.C. is investigating claims on behalf of investors of Bristol-Myers Squibb Company (NYSE: BMY) to determine whether Bristol-Myers and certain of its officers and/or …